PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
May 6, 2026Egyptian Journal of Bronchology0 citationsOpen Access

Cardiopulmonary functional profiles in systemic lupus erythematosus–associated pulmonary hypertension: a spirometric and echocardiographic study

AMAhmed MadyYSYoussef SolimanNTNezar Refaat Tawfik

Key Points

  • This study aims to characterize the functional profiles of pulmonary hypertension in systemic lupus erythematosus.
  • Sixty patients with systemic lupus erythematosus-associated pulmonary hypertension were prospectively analyzed.
  • Participants were classified into four subgroups based on the type of pulmonary hypertension.
  • Spirometric and echocardiographic variables were compared using ANOVA and Fisher’s exact test.
  • Forced vital capacity differed significantly with reduced values in the interstitial lung disease subgroup (p=0.017).
  • The left ventricular dysfunction subgroup showed markedly reduced ejection fraction (EF) (p<0.001) and elevated estimated pulmonary artery pressure (EPAP) (p=0.037).
  • Dyspnea severity varied significantly among groups (p=0.018).

Abstract

Abstract Background Pulmonary hypertension (PH) is a serious and potentially life-threatening complication of systemic lupus erythematosus (SLE). Functional characterization may facilitate the differentiation of the heterogeneous phenotypes of systemic lupus erythematosus–associated pulmonary hypertension (SLE-PH). Methods Sixty patients with SLE-PH were prospectively analyzed and classified into four groups: SLE-associated pulmonary arterial hypertension (SLE-PAH; n = 15), SLE with left ventricular (LV) dysfunction ( n = 20), SLE with interstitial lung disease–associated pulmonary hypertension (ILD-PH; n = 21), and chronic thromboembolic pulmonary hypertension (CTEPH; n = 4). Spirometric, echocardiographic, and clinical variables were compared using one-way analysis of variance (ANOVA) with least significant difference (LSD) post-hoc testing and Fisher’s exact test. Results Airflow indices were comparable across groups. In contrast, forced vital capacity (FVC) differed significantly ( p = 0.017), with reduced values observed in the ILD-PH subgroup. The LV dysfunction subgroup demonstrated markedly reduced ejection fraction (EF) ( p < 0.001) and elevated estimated pulmonary artery pressure (EPAP) ( p = 0.037). Post-hoc analysis identified significant pairwise differences in forced expiratory volume in 1 s (FEV₁), FEV₁/FVC ratio, and EPAP. Dyspnea severity also differed significantly among groups ( p = 0.018). Conclusions SLE-PH demonstrates distinct cardiopulmonary functional phenotypes. The combined use of spirometry and echocardiography provides a practical, non-invasive approach for early phenotypic characterization, with potential implications for risk stratification and individualized management.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Mady et al. (2026) studied this question.

synapsesocial.com/papers/69fadad703f892aec9b1e859https://doi.org/10.1186/s43168-026-00572-w
Ask AI
Helpful
Bookmark
Share
View Full Paper